These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7195962)

  • 1. Combination chemotherapy in a prostate tumor model: Nb rat prostatic adenocarcinoma model.
    Drago JR; Worgul T; Gershwin ME
    J Surg Oncol; 1981; 16(4):353-63. PubMed ID: 7195962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic treatment of the Nb rat adenocarcinoma androgen-insensitive tumor III.
    Drago JR
    J Surg Oncol; 1982 Dec; 21(4):264-6. PubMed ID: 7144207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of an Nb-Pr-A.I.-3 (autonomous) tumor with combination chemotherapy.
    Drago JR; Worgul T
    Cancer Chemother Pharmacol; 1981; 5(3):163-6. PubMed ID: 7197592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of the Nb rat in combination chemotherapeutic experiments for prostate cancer.
    Drago JR; Smith J
    In Vivo; 1991; 5(1):41-2. PubMed ID: 1932624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple drug chemotherapy in treatment of prostate adenocarcinoma Nb Pr A.I.-III.
    Drago JR; Worgul TJ
    Invest Urol; 1981 Nov; 19(3):191-3. PubMed ID: 7298290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nb rat prostate adenocarcinoma model: evaluation of the subrenal capsular assay system.
    Drago JR; Lombard J
    J Surg Oncol; 1985 Apr; 28(4):270-2. PubMed ID: 3884903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat prostate adenocarcinoma: autonomous tumor (18-Pr and 13-Pr).
    Drago JR; Goldman LB; Gershwin ME
    Cancer; 1980 Jul; 46(2):273-8. PubMed ID: 7388771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Nb rat prostatic adenocarcinoma's dose response to methotrexate and adriamycin.
    Drago JR; Palmer J
    J Surg Oncol; 1983 Nov; 24(3):215-7. PubMed ID: 6632910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic manipulation of Nb rat prostatic adenocarcinomas: chemotherapeutic evaluation of autonomous tumors.
    Drago JR; Goldman LB; Maurer RE; Gershwin ME; Eckels DD
    Invest Urol; 1979 Nov; 17(3):203-6. PubMed ID: 500317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further experience with chemotherapy in the Dunning prostatic adenocarcinoma.
    Block NL; Camuzzi F; Stover B; Claflin A; Troner M; Politano VA
    Trans Am Assoc Genitourin Surg; 1978; 70():57-9. PubMed ID: 753023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The chemotherapy of prostatic adenocarcinoma.
    Torti FM; Carter SK
    Ann Intern Med; 1980 May; 92(5):681-9. PubMed ID: 6992675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adriamycin-vitamin E combination therapy for treatment of prostate adenocarcinoma in the Nb rat model.
    Nesbitt JA; Smith J; McDowell G; Drago JR
    J Surg Oncol; 1988 Aug; 38(4):283-4. PubMed ID: 3411971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of the transplantable adenocarcinoma (R-3327) of the Copenhagen rat.
    Block NL; Camuzzi F; Denefrio J; Troner M; Claflin A; Stover B; Politano VA
    Oncology; 1977; 34(3):110-3. PubMed ID: 917440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
    Drago JR; Goldman L; Gershwin ME
    Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of the usefulness of endocrine therapy combined with chemotherapy as an initial treatment of prostatic cancer].
    Matsuoka K; Yoshitake N; Noguti M; Tanaka H; Noda S; Eto K
    Nihon Hinyokika Gakkai Zasshi; 1988 Sep; 79(9):1559-66. PubMed ID: 3244222
    [No Abstract]   [Full Text] [Related]  

  • 16. Chemotesting of prostate cancer in xenografts.
    Byard MA; Smith JJ; Drago JR
    J Surg Oncol; 1989 Jul; 41(3):198-200. PubMed ID: 2747245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemotherapy for advanced gynecological carcinoma with cis-dichlorodiammineplatinum (II), adriamycin and/or cyclophosphamide after failure of initial treatment (author's transl)].
    Takizawa K; Matsuzawa M; Takahashi M; So E; Hasumi K; Sampi K
    Nihon Gan Chiryo Gakkai Shi; 1981 Oct; 16(6):1292-1302. PubMed ID: 7199554
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat (Pr-90) prostatic carcinoma.
    Drago JR; Goldman LB
    Cancer; 1980 Feb; 45(4):757-63. PubMed ID: 7357493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclophosphamide (NSC 26271) versus the combination of adriamycin (NSC 123127), 5-fluorouracil (NSC 19893), and cyclophosphamide in the treatment of metastatic prostatic cancer: a randomized trial.
    Chlebowski RT; Hestorff R; Sardoff L; Weiner J; Bateman JR
    Cancer; 1978 Dec; 42(6):2546-52. PubMed ID: 365313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy and concomitant chemoradiotherapy in the NB rat prostate adenocarcinoma model.
    Klump R; Pieters RS; Smith JJ; Badalament RA; Drago JR
    In Vivo; 1989; 3(2):109-11. PubMed ID: 2519835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.